UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...
NEWARK, Calif., July 28, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company...
NEWARK, Calif., July 25, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD), a leading stem cell company...
NEWARK, Calif., July 22, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD) announced today publication...
NEWARK, Calif., July 21, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD), a leading stem cell company...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
After years of being swatted about like ping-pong balls, are stem-cell stocks now worth a second look? Perhaps no other medical subsector has had...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) STEMCELLS INC...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.